GetTopicDetailResponse(id=6ed0112e5756, topicName=大葉茜草素, introduction=大葉茜草素, content=大葉茜草素 膿毒癥, image=null, comments=1, allHits=1181, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Mar 26 11:17:01 CST 2024, time=2024-03-26, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=488781, tagList=[TagDto(tagId=488781, tagName=大葉茜草素)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2205222, encodeId=8034220522260, content=<a href='/topic/show?id=7a2f851921d' target=_blank style='color:#2F92EE;'>#膿毒癥#</a> <a href='/topic/show?id=6ed0112e5756' target=_blank style='color:#2F92EE;'>#大葉茜草素#</a>, objectTitle=干法和濕法實驗雙重揭示：大葉茜草素可有望成為膿毒癥的候選藥物, objectType=article, longId=826344, objectId=0026826344c8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240517/1715931729672_8538692.jpg, objectUrl=/article/show_article.do?id=0026826344c8, replyNumber=0, likeNumber=0, createdTime=2024-05-17, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0026826344c8, moduleTitle=干法和濕法實驗雙重揭示：大葉茜草素可有望成為膿毒癥的候選藥物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0026826344c8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195581, encodeId=dee52195581fc, content=<a href='/topic/show?id=6ed0112e5756' target=_blank style='color:#2F92EE;'>#大葉茜草素#</a>（Mollugin, MLG）是<a href='/topic/show?id=0dc3112e862e' target=_blank style='color:#2F92EE;'>#茜草#</a>（Rubia cordifolia L.）的主要活性成分之一，已證明有抗炎、抗病毒和抗癌作用。這次認為可以治療<a href='/topic/show?id=7a2f851921d' target=_blank style='color:#2F92EE;'>#膿毒癥#</a>，證據(jù)仍然不夠!
茜草在<a href='/topic/show?id=c01b2138812' target=_blank style='color:#2F92EE;'>#中醫(yī)#</a>中認為具有<a href='/topic/show?id=41b0112e877c' target=_blank style='color:#2F92EE;'>#涼血止血#</a>、<a href='/topic/show?id=bc16103825ac' target=_blank style='color:#2F92EE;'>#活血化瘀#</a>。主血熱咯血、吐血、衄血、<a href='/topic/show?id=e1eb4e509a1' target=_blank style='color:#2F92EE;'>#尿血#</a>、便血、<a href='/topic/show?id=908b112e8842' target=_blank style='color:#2F92EE;'>#崩漏#</a>、經(jīng)閉、產(chǎn)后瘀阻腹痛、<a href='/topic/show?id=24151045e68f' target=_blank style='color:#2F92EE;'>#跌打損傷#</a>、<a href='/topic/show?id=322f112e8993' target=_blank style='color:#2F92EE;'>#風(fēng)濕痹痛#</a>、黃疸、瘡癰、痔腫；可能確實有一定的止血，抗炎作用，但是其作用可能不一定有真正的抗感染的作用的。, objectTitle=Int Immunopharmacol：大葉茜草素可有望成為膿毒癥的候選藥物, objectType=article, longId=818030, objectId=e5e1818030bc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240326/1711423824790_8538692.jpg, objectUrl=/article/show_article.do?id=e5e1818030bc, replyNumber=0, likeNumber=126, createdTime=2024-03-27, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=e5e1818030bc, moduleTitle=Int Immunopharmacol：大葉茜草素可有望成為膿毒癥的候選藥物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e5e1818030bc)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2195411, encodeId=913f219541188, content=<a href='/topic/show?id=6ed0112e5756' target=_blank style='color:#2F92EE;'>#大葉茜草素#</a> <a href='/topic/show?id=7a2f851921d' target=_blank style='color:#2F92EE;'>#膿毒癥#</a>, objectTitle=干法和濕法實驗雙重揭示：大葉茜草素可有望成為膿毒癥的候選藥物, objectType=article, longId=818030, objectId=e5e1818030bc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240318/535d09075359452b8715594a838f3835-2cKPxjic9SAv.jpg, objectUrl=/article/show_article.do?id=e5e1818030bc, replyNumber=0, likeNumber=106, createdTime=2024-03-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e5e1818030bc, moduleTitle=干法和濕法實驗雙重揭示：大葉茜草素可有望成為膿毒癥的候選藥物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e5e1818030bc)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-03-26發(fā)表于上海
